|
209
|
564
|
3cj0A |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small molecule fragments |
|
202
|
564
|
3cj3A |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized small molecule fragments |
|
203
|
564
|
3cizA |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small molecule fragments |
|
198
|
563
|
3cj4A |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized small molecule fragments |
|
205
|
562
|
3cj2A |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized small molecule fragments |
|
206
|
562
|
3cdeA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
198
|
562
|
3co9A |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
201
|
564
|
3cj5A |
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized small molecule fragments |
|
207
|
562
|
3bsaA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
212
|
562
|
3br9A |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
203
|
562
|
3bscA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
205
|
566
|
2zkuA |
Structure of hepatitis c virus ns5b polymerase in a new crystal form |
|
205
|
568
|
2yojA |
Hcv ns5b polymerase complexed with pyridonylindole compound |
|
142
|
444
|
2zjoA |
Crystal structure of hepatitis c virus ns3 helicase with a novel inhibitor |
|
208
|
563
|
2xwhA |
Hcv-j6 ns5b polymerase structure at 1.8 angstrom |
|
186
|
531
|
2xwyA |
Structure of mk-3281, a potent non-nucleoside finger-loop inhibitor, in complex with the hepatitis c virus ns5b polymerase |
|
212
|
563
|
2xxdA |
Hcv-jfh1 ns5b polymerase structure at 1.9 angstrom |
|
215
|
563
|
2xymA |
Hcv-jfh1 ns5b t385a mutant |
|
207
|
562
|
2xi2A |
Hcv-h77 ns5b apo polymerase |
|
35
|
181
|
2xniA |
Protein-ligand complex of a novel macrocyclic hcv ns3 protease inhibitor derived from amino cyclic boronates |
|
204
|
562
|
2xi3A |
Hcv-h77 ns5b polymerase complexed with gtp |
|
199
|
563
|
2xhvA |
Hcv-j4 ns5b polymerase point mutant orthorhombic crystal form |
|
199
|
563
|
2xhwA |
Hcv-j4 ns5b polymerase trigonal crystal form |
|
205
|
563
|
2xhuA |
Hcv-j4 ns5b polymerase orthorhombic crystal form |
|
186
|
531
|
2whoA |
Crystal structure of hepatitis c virus ns5b polymerase from 1b genotype in complex with a non-nucleoside inhibitor |
|
198
|
531
|
2wrmA |
Identification of novel allosteric inhibitors of hepatitis c virus ns5b polymerase thumb domain (site ii) by structure-based design |
|
198
|
531
|
2wcxA |
Crystal structure of hepatitis c virus ns5b polymerase in complex with thienopyrrole-based finger-loop inhibitors |
|
1
|
16
|
2qv1C |
Crystal structure of hcv ns3-4a v36m mutant |
|
0
|
16
|
2p59C |
Crystal structure of hepatitis c virus ns3.4a protease |
|
39
|
180
|
2obqA |
Discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization |
|
46
|
183
|
2oc1A |
Structure of the hcv ns3/4a protease inhibitor cvs4819 |
|
34
|
151
|
2oinA |
Crystal structure of hcv ns3-4a r155k muntant |
|
0
|
22
|
2oc1B |
Structure of the hcv ns3/4a protease inhibitor cvs4819 |
|
41
|
181
|
2oc7A |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 |
|
42
|
183
|
2oc8A |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 |
|
1
|
16
|
2oinC |
Crystal structure of hcv ns3-4a r155k muntant |
|
0
|
22
|
2oc7B |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 |
|
0
|
22
|
2oc0B |
Structure of ns3 complexed with a ketoamide inhibitor sch491762 |
|
44
|
185
|
2o8mA |
Crystal structure of the s139a mutant of hepatitis c virus ns3/4a protease |
|
202
|
564
|
2o5dA |
Thiazolone-acylsulfonamides as novel hcv ns5b polymerase allosteric inhibitors: convergence of structure-based drug design and x-ray crystallographic study |
|
0
|
22
|
2oc8B |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 |
|
40
|
181
|
2oc0A |
Structure of ns3 complexed with a ketoamide inhibitor sch491762 |
|
0
|
23
|
2o8mC |
Crystal structure of the s139a mutant of hepatitis c virus ns3/4a protease |
|
5
|
27
|
2lifA |
Solution structure of kkgf |
|
11
|
63
|
2m6xA |
Structure of the p7 channel of hepatitis c virus, genotype 5a |
|
12
|
63
|
2mtsA |
Three-dimensional structure and interaction studies of hepatitis c virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance |
|
7
|
31
|
2lzpA |
Structure of ns2(2-32) gbvb protein |
|
8
|
40
|
2kwzA |
Solution structure of ns2 [60-99] |
|
4
|
29
|
2k8jX |
Solution structure of hcv p7 tm2 |
|
7
|
25
|
2mkbA |
Structure of ns2(113-137) gbvb protein |
